Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,198,591
-
Share change
-
+7,197,591
-
Total reported value
-
$77,547,000
-
Put/Call ratio
-
57%
-
Price per share
-
$11.61
-
Number of holders
-
32
-
Value change
-
+$77,536,073
-
Number of buys
-
31
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2021
As of 30 Sep 2021 Humacyte, Inc. - COM (HUMA) had 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,198,591 shares of stock of the company.
Largest 10 holders included York Capital Management Global Advisors, LLC, ORBIMED ADVISORS LLC, Diameter Capital Partners LP, Monashee Investment Management LLC, Maven Securities LTD, CVI Holdings, LLC, VANGUARD GROUP INC, LPL Financial LLC, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 32 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.